02-07-2020 18:45 via medpagetoday.com

Pooled Data Back Short-Course HCV Tx

(MedPage Today) -- A short-course treatment of glecaprevir-pibrentasvir (Mavyret) was efficacious and well tolerated in treatment-naive patients with all hepatitis C virus (HCV) genotype infections with or without cirrhosis, international researchers...
Read more »